01501 INT MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.24X | Oper Margin | 25.5% |
|---|---|---|---|
| LT Debt/Equity | 9.4% | Net Margin | 19.4% |
| Total Debt/Equity | 35.9% | Return on Equity | 10.3% |
| Price/Book | 2.70X | Return on Assets | 6.6% |
| (HKD 34.120) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 229.55 | 192.41 | 167.40 | 147.68 | 174.85 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +19.3 | +14.9 | +13.4 | -15.5 | +21.4 |
| Earnings Per Share (HKD) | 1.398 | 1.17 | 1.009 | 0.89 | 1.053 |
| Earnings Per Share Growth (%) | +19.5 | +15.9 | +13.5 | -15.5 | +21.4 |
| Dividend Per Share (HKD) | 0.260 | No dividend | 0.300 | 0.270 | 0.320 |
| P/E* (X) | 24.41 | 29.17 | 33.81 | 38.35 | 32.39 |
| Yield (%) | 0.76 | N/A | 0.88 | 0.79 | 0.94 |
| Dividend Share (%) | 18.60 | N/A | 29.72 | 30.35 | 30.38 |
| Book NAV (HKD) | 12.619 | 10.721 | 10.630 | 10.091 | 10.282 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,065 | 851.954 | +25.0 | 752.836 |
| Operating Result | 258.907 | 213.779 | +21.1 | 175.128 |
| Associates | -0.585 | -0.395 | +48.1 | 0 |
| Profit Before Taxation | 258.322 | 213.384 | +21.1 | 175.128 |
| Taxation | 25.648 | 23.335 | +9.9 | 21.9 |
| Profit /( Loss) After Taxation | 232.674 | 190.049 | +22.4 | 153.228 |
| Minority Interests | 13.888 | -1.865 | -844.7 | -3.229 |
| Net Profit | 206.23 | 180.917 | +14.0 | 151.882 |
| Earnings Per Share () | 1.3976 | 1.1696 | +19.5 | 1.0093 |
| Dividend Per Share () | 0.2600 | 0.0000 | N/A | 0.3000 |
| Announcement Date | 2026-03-27 | 2025-03-18 | NA | 2024-03-18 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
